200,000+ products from a single source!

sales@angenechem.com

Home > Nitro Compounds > 80508-23-2

80508-23-2

80508-23-2 | 3-(1-nitrosopyrrolidin-2-yl)pyridine

CAS No: 80508-23-2 Catalog No: AG0052J2 MDL No:

Product Description

Catalog Number:
AG0052J2
Chemical Name:
3-(1-nitrosopyrrolidin-2-yl)pyridine
CAS Number:
80508-23-2
Molecular Formula:
C9H11N3O
Molecular Weight:
177.2031
IUPAC Name:
3-(1-nitrosopyrrolidin-2-yl)pyridine
InChI:
InChI=1S/C9H11N3O/c13-11-12-6-2-4-9(12)8-3-1-5-10-7-8/h1,3,5,7,9H,2,4,6H2
InChI Key:
XKABJYQDMJTNGQ-UHFFFAOYSA-N
SMILES:
O=NN1CCCC1c1cccnc1
UN Number:
2810

Properties

Complexity:
186  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
177.09g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
177.207g/mol
Monoisotopic Mass:
177.09g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
45.6A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
1.1  

Literature

Title Journal
In vitro metabolism of N'-Nitrosonornicotine catalyzed by cytochrome P450 2A13 and its inhibition by nicotine, N'-Nitrosoanatabine and N'-Nitrosoanabasine. Chemico-biological interactions 20161225
In vitro exposure of tobacco specific nitrosamines decreases the rat lung phospholipids by enhanced phospholipase A2 activity. Toxicology in vitro : an international journal published in association with BIBRA 20140901
Analysis of N'-nitrosonornicotine and its metabolites in rabbit blood with liquid chromatography/tandem mass spectrometric method. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120615
Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products. Tobacco control 20111101
Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Carcinogenesis 20110901
Environmental mutagens may be implicated in the emergence of drug-resistant microorganisms. FEMS microbiology letters 20110401
Enhanced phospholipase B activity and alteration of phospholipids and neutral lipids in Saccharomyces cerevisiae exposed to N-nitrosonornicotine. Antonie van Leeuwenhoek 20110301
Three nicotine demethylase genes mediate nornicotine biosynthesis in Nicotiana tabacum L.: functional characterization of the CYP82E10 gene. Phytochemistry 20101201
Adsorption of nitrosamines by mesoporous zeolite. Journal of colloid and interface science 20100815
[Determination of four carcinogens in mainstream cigarette smoke by liquid chromatography-tandem mass spectrometry]. Se pu = Chinese journal of chromatography 20100801
Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20091201
Incremental lifetime cancer risks computed for benzo[a]pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data. Regulatory toxicology and pharmacology : RTP 20091101
Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer research 20091101
The influence of repair pathways on the cytotoxicity and mutagenicity induced by the pyridyloxobutylation pathway of tobacco-specific nitrosamines. Chemical research in toxicology 20090817
Quantitation of pyridyloxobutyl DNA adducts in nasal and oral mucosa of rats treated chronically with enantiomers of N'-nitrosonornicotine. Chemical research in toxicology 20090501
Effect of CYP2A13 active site mutation N297A on metabolism of coumarin and tobacco-specific nitrosamines. Drug metabolism and disposition: the biological fate of chemicals 20090301
Evaluation of the mutagenic effects of myosmine in human lymphocytes using the HPRT gene mutation assay. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20090101
Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20090101
CYP2A6 polymorphisms and risk for tobacco-related cancers. Pharmacogenomics 20081101
Mouse model of diethylnitrosamine-induced gastric cancer. The Journal of surgical research 20080801
Glucuronidation of tobacco-specific nitrosamines by UGT2B10. Drug metabolism and disposition: the biological fate of chemicals 20080501
RNA interference (RNAi)-induced suppression of nicotine demethylase activity reduces levels of a key carcinogen in cured tobacco leaves. Plant biotechnology journal 20080501
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 20080403
Detection and quantitation of N'-nitrosonornicotine in human toenails by liquid chromatography-electrospray ionization-tandem mass spectrometry. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20080401
Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors. Journal of pharmacological sciences 20080201
Functional characterization of CYP2A13 polymorphisms. Xenobiotica; the fate of foreign compounds in biological systems 20071201
Endogenous formation of N'-nitrosonornicotine in F344 rats in the presence of some antioxidants and grape seed extract. Journal of agricultural and food chemistry 20070822
SLURP-1 and -2 in normal, immortalized and malignant oral keratinocytes. Life sciences 20070530
Nitrosamines as nicotinic receptor ligands. Life sciences 20070530
A new method for estimating the retention of selected smoke constituents in the respiratory tract of smokers during cigarette smoking. Inhalation toxicology 20070201
Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N'-nitrosonornicotine. Chemical research in toxicology 20070201
Development of a commercial cigarette 'market map' comparison methodology for evaluating new or non-conventional cigarettes. Regulatory toxicology and pharmacology : RTP 20061201
The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells. Journal of cancer research and clinical oncology 20061001
Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells. Cancer biology & therapy 20060501
Acute and subacute effects of tobacco alkaloids, tobacco-specific nitrosamines and phenethyl isothiocyanate on N'-nitrosonornicotine metabolism in rats. Toxicology 20051115
Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. International journal of cancer 20050810
Nicotine 5'-oxidation and methyl oxidation by P450 2A enzymes. Drug metabolism and disposition: the biological fate of chemicals 20050801
Duodenal acidity may increase the risk of pancreatic cancer in the course of chronic pancreatitis: an etiopathogenetic hypothesis. JOP : Journal of the pancreas 20050310
Effect of N'-nitrosonornicotine (NNN) on murine palatal fusion in vitro. Toxicology 20050227
Inhibition by N'-nitrosonornicotine of the catalytic activity of glutamate dehydrogenase in alpha-ketoglutarate amination. Journal of enzyme inhibition and medicinal chemistry 20050201
Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine. Chemical research in toxicology 20050101
Tobacco-related-compound-induced nitrosative stress injury in the hamster cheek pouch. Journal of dental research 20041201
Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA. Chemical research in toxicology 20040501
Effect of ethanol on lipid metabolism and epithelial permeability barrier of skin and oral mucosa in the rat. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20031101
The permeability of oral leukoplakia. European journal of oral sciences 20030801
Nucleophilic reactions between thiols and a tobacco specific nitrosamine metabolite, 4-hydroxy-1-(3-pyridyl)-1-butanone. Chemical research in toxicology 20030501
[Cancer from snuff?]. HNO 20030301
Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. The Journal of clinical investigation 20030101
Metabolism and pharmacokinetics of N'-nitrosonornicotine in the patas monkey. Drug metabolism and disposition: the biological fate of chemicals 20021001
Nitrosation of dietary myosmine as risk factor of human cancer. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20020801
Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP. Drug metabolism reviews 20020801
Analysis of tobacco-specific nitrosamines in Moldovan cigarette tobacco. Journal of agricultural and food chemistry 20020508
Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mixtures. Mutation research 20010531
Preparation of pyridine-N-glucuronides of tobacco-specific nitrosamines. Chemical research in toxicology 20010501
Tobacco industry must not dump its high nitrosamine tobacco on poor countries. BMJ (Clinical research ed.) 20010303
Mutagenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosonornicotine in lacZ upper aerodigestive tissue and liver and inhibition by green tea. Carcinogenesis 20010101
Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase. Environmental and molecular mutagenesis 20010101
Smoke yields of tobacco-specific nitrosamines in relation to FTC tar level and cigarette manufacturer: analysis of the Massachusetts Benchmark Study. Public health reports (Washington, D.C. : 1974) 20010101
Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes. Drug metabolism and disposition: the biological fate of chemicals 19970201
A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 19910701
Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer research 19800201
Carcinogenicity of N'-nitrosonornicotine in Sprague-Dawley rats. Journal of the National Cancer Institute 19761201

© 2019 Angene International Limited. All rights Reserved.